The ten genes for breast (and ovarian) cancer susceptibility

被引:0
|
作者
William D. Foulkes
机构
[1] McGill University,Departments of Medicine, Human Genetics and Oncology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
ATM, BRCA1, BRCA2, CHEK2, PALB2 and TP53 are all established breast cancer susceptibility genes. Over the past 30 years, many other genes have been proposed as candidates. In these two large studies, the candidacy of several questionable genes has been largely resolved, and a final list of ten genes for breast and, importantly, ovarian cancer risk has emerged.
引用
收藏
页码:259 / 260
页数:1
相关论文
共 50 条
  • [31] Predisposing genes in hereditary breast and ovarian cancer
    Huusko, P
    ANNALES CHIRURGIAE ET GYNAECOLOGIAE, 2000, 89 (04) : 320 - 320
  • [32] Mutation characteristics of cancer susceptibility genes in Chinese ovarian cancer patients
    Wang, Jie
    Fu, Kaiyu
    Zhang, Mengpei
    Liang, Lunggang
    Ni, Meng
    Sun, Hai-Xi
    Yin, Rutie
    Tang, Meifang
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [33] Laboratory determination of hereditary susceptibility to breast and ovarian cancer
    Frank, TS
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1999, 123 (11) : 1023 - 1026
  • [34] The BOADICEA model of genetic susceptibility to breast and ovarian cancer
    Antoniou, AC
    Pharoah, PPD
    Smith, P
    Easton, DF
    BRITISH JOURNAL OF CANCER, 2004, 91 (08) : 1580 - 1590
  • [35] The BOADICEA model of genetic susceptibility to breast and ovarian cancer
    A C Antoniou
    P P D Pharoah
    P Smith
    D F Easton
    British Journal of Cancer, 2004, 91 : 1580 - 1590
  • [36] Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes
    Wang, Jiayu
    Li, Weiwei
    Shi, Yujian
    Huang, Yan
    Sun, Tao
    Tang, Lili
    Lu, Qing
    Lei, Qiumo
    Liao, Ning
    Jin, Feng
    Li, Hui
    Huang, Tao
    Qian, Jun
    Pang, Danmei
    Wang, Shusen
    Fan, Peizhi
    Wu, Xinhong
    Lin, Ying
    Qin, Haiyan
    Xu, Binghe
    CANCER MEDICINE, 2019, 8 (05): : 2074 - 2084
  • [37] Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels
    Lee, Kristy
    Seifert, Bryce A.
    Shimelis, Hermela
    Ghosh, Rajarshi
    Crowley, Stephanie B.
    Carter, Natalie J.
    Doonanco, Kurston
    Foreman, A. Katherine
    Ritter, Deborah I.
    Jimenez, Sharisse
    Trapp, Mackenzie
    Offit, Kenneth
    Plon, Sharon E.
    Couch, Fergus J.
    GENETICS IN MEDICINE, 2019, 21 (07) : 1497 - 1506
  • [38] Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel
    Tamar Yablonski-Peretz
    Shani Paluch-Shimon
    Lior Soussan Gutman
    Yulia Kaplan
    Addie Dvir
    Inbal Barnes-Kedar
    Luna Kadouri
    Valeriya Semenisty
    Noa Efrat
    Victoria Neiman
    Yafit Glasser
    Rachel Michaelson-Cohen
    Lior Katz
    Bella Kaufman
    Talia Golan
    Orit Reish
    Ayala Hubert
    Tamar Safra
    Yuval Yaron
    Eitan Friedman
    Breast Cancer Research and Treatment, 2016, 155 : 133 - 138
  • [39] The power of next generation sequencing in the detection of breast and ovarian cancer susceptibility genes other than BRCA
    Eliade, M.
    Skrypski, J.
    Baurand, A.
    Jacquot, C.
    Bertolone, G.
    Loustalot, C.
    Coutant, C.
    Guy, F.
    Fumoleau, P.
    Riviere, J-B
    Duffourd, Y.
    Ghiringhelli, F.
    Vegran, F.
    Boidot, R.
    Lizard, S.
    Faivre, L.
    CANCER RESEARCH, 2016, 76
  • [40] Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel
    Yablonski-Peretz, Tamar
    Paluch-Shimon, Shani
    Gutman, Lior Soussan
    Kaplan, Yulia
    Dvir, Addie
    Barnes-Kedar, Inbal
    Kadouri, Luna
    Semenisty, Valeriya
    Efrat, Noa
    Neiman, Victoria
    Glasser, Yafit
    Michaelson-Cohen, Rachel
    Katz, Lior
    Kaufman, Bella
    Golan, Talia
    Reish, Orit
    Hubert, Ayala
    Safra, Tamar
    Yaron, Yuval
    Friedman, Eitan
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (01) : 133 - 138